Paragonix Technologies, a leading organ transplant company, recently announced that it has reached a definitive agreement to be acquired by Getinge.

This strategic acquisition will expand Getinge’s global healthcare portfolio to meet needs in solid organ transplantation.

Getinge’s global reach will expand the reach of Paragonix’s innovative transplant technologies into new markets, while also creating opportunities to combine the two companies’ organ preservation and blood perfusion technologies for new innovations. Paragonix and Getinge share the vision of providing market-leading solutions across the full spectrum of transplant care.

The Knobbe Martens team advising Paragonix includes Sabing Lee, Ph.D., co-chair of the firm’s medical devices and procedures practice. There were David Schmidt, Catherine Holland and James Raleigh.

“Every day, we are inspired to deliver new, life-changing innovations to the transplant and donation communities. “We offer our deepest gratitude to the clinic and donor community for the opportunity to serve.”

Paragonix has pioneered the development of a groundbreaking platform of organ preservation technologies, sparking a shift in the clinical transplant community and redefining the standard of care in organ transplantation. Today, Paragonix is ​​the leading U.S. provider of cardiothoracic organ preservation technology and is rapidly growing in abdominal transplantation.

Paragonix has developed a robust portfolio to meet the needs of the transplant community, including leading clinical research initiatives, intelligent digital logistics platforms, and national clinical service networks. By combining this leadership in transplantation with Getinge’s extensive resources and global distribution network, the acquisition will accelerate the availability of this transformative medical technology. The agreement will also encourage the creation of new technologies that meet critical global health needs.

The boards of directors of both Paragonix and Getinge have approved the transaction pending satisfaction of customary closing conditions. Following closing, Paragonix will become a wholly owned subsidiary of Getinge.

Sheppard, Mullin, Richter & Hampton LLP served as legal counsel, Knobbe Martens served as Olson & Bear Intellectual Property counsel, and UBS Investment Bank Securities is serving as exclusive financial advisor to Paragonix.

Knobbe Martens serves a broad international customer base, from multinational corporations to emerging businesses at all stages.